![]() Iopamidol structure
|
Common Name | Iopamidol | ||
---|---|---|---|---|
CAS Number | 60166-93-0 | Molecular Weight | 777.085 | |
Density | 2.3±0.1 g/cm3 | Boiling Point | 785.3±60.0 °C at 760 mmHg | |
Molecular Formula | C17H22I3N3O8 | Melting Point | >320ºC (dec) | |
MSDS | N/A | Flash Point | 428.8±32.9 °C |
Use of IopamidolIopamidol (B-15000; SQ-13396) is a nonionic, low-osmolar iodinated contrast agent. |
Name | (S)-N,N′-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5-lactamidoisophthalamide |
---|---|
Synonym | More Synonyms |
Description | Iopamidol (B-15000; SQ-13396) is a nonionic, low-osmolar iodinated contrast agent. |
---|---|
Related Catalog | |
References |
Density | 2.3±0.1 g/cm3 |
---|---|
Boiling Point | 785.3±60.0 °C at 760 mmHg |
Melting Point | >320ºC (dec) |
Molecular Formula | C17H22I3N3O8 |
Molecular Weight | 777.085 |
Flash Point | 428.8±32.9 °C |
Exact Mass | 776.854065 |
PSA | 188.45000 |
LogP | -2.09 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.739 |
Storage condition | -20?C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 2924299090 |
~96% Iopamidol CAS#:60166-93-0 |
Literature: EP883597 B1, ; Page/Page column 6-7 ; |
~% Iopamidol CAS#:60166-93-0 |
Literature: WO2012/175903 A1, ; |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Low contrast and radiation dose coronary CT angiography using a 320-row system and a refined contrast injection and timing method.
J. Cardiovasc. Comput. Tomogr. 9(1) , 19-27, (2015) Among CT scanners, 320-row instruments feature decreased photon energy and yield strong contrast enhancement. Consequently, the contrast medium (CM) dose can be reduced. The results of low-tube-voltag... |
|
Influence of the motion correction algorithm on the quality and interpretability of images of single-source 64-detector coronary CT angiography among patients grouped by heart rate.
Jpn. J. Radiol. 33(2) , 84-93, (2015) We retrospectively investigated the effect of the motion correction algorithm (MCA) on image quality and interpretability by heart rate (HR) in coronary CT angiography (CCTA).For 105 patients (6 HR gr... |
|
Evaluation of the predictive value of coronary artery calcium score for obstructive coronary artery disease in asymptomatic Korean patients with type 2 diabetes mellitus.
Coron. Artery Dis. 26(2) , 150-6, (2015) Compared with coronary computed tomographic angiography (CCTA), the coronary artery calcium score (CACS) may be limited in predicting adverse cardiovascular events in asymptomatic diabetic patients.We... |
1,3-benzenedicarboxamide, N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo- |
UNII:JR13W81H44 |
1,3-benzenedicarboxamide, N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo- |
N,N'-Bis(1,3-dihydroxy-2-propanyl)-2,4,6-triiodo-5-(lactoylamino)isophthalamide |
N,N'-Bis(1,3-dihydroxy-2-propanyl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodoisophthalamide |
Iopamiron |
EINECS 262-093-6 |
N,N'-bis[2-hydroxy-1-(hydroxyméthyl)éthyl]-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzène-1,3-dicarboxamide |
(S)-N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5-lactamidoisophthalamide |
1,3-benzenedicarboxamide, N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo- |
N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodbenzol-1,3-dicarboxamid |
1,3-Benzenedicarboxamide, N,N-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo- |
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide |
Iopamidol |
1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo- |
Isovue |
MFCD00867931 |
1,3-Benzenedicarboxamide, N,N-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo- |
5-(a-Hydroxypropionylamino)-2,4,6-triiodoisophthalic Acid Di(1,3-dihydroxyisopropylamide) |
Iopamiro |
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxypropanoyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide |
(s)-n,n'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodo-5-lactamidoisophthalamide |
N,N'-bis(1,3-dihydroxypropan-2-yl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide |
(S)-N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide |
Solutrast |
iomapidol |
N,N'-Bis(1,3-dihydroxypropan-2-yl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodoisophthalamide |
Jopamiro |